"Monitoring the Effectiveness of Surgical Treatment of Malignant Pleural Effusions"@en . . "7"^^ . "Monitorace efektivity chirurgick\u00E9 l\u00E9\u010Dby malign\u00EDch pleur\u00E1ln\u00EDch v\u00FDpotk\u016F"@cs . "Klinicka Onkologie" . . . . "Krejsek, Jan" . "CZ - \u010Cesk\u00E1 republika" . "Jankovi\u010Dov\u00E1, Karol\u00EDna" . "V\u00FDchodiska: Recidivuj\u00EDc\u00ED pleur\u00E1ln\u00ED v\u00FDpotky doprov\u00E1zej\u00ED asi 10 % malign\u00EDch onemocn\u011Bn\u00ED. Opakovan\u00E9 hrudn\u00ED punkce \u010Di dren\u00E1\u017Ee mohou b\u00FDt komplikov\u00E1ny pneumotoraxem, hemotoraxem nebo infekc\u00ED pleur\u00E1ln\u00ED dutiny. Aplikace pr\u00E1\u0161kov\u00E9 formy bio talku torakoskopicky pat\u0159\u00ED k nejefektivn\u011Bj\u0161\u00EDmu paliativn\u00EDmu zp\u016Fsobu l\u00E9\u010Dby. \u00DAsp\u011B\u0161nost se pohybuje kolem 70- 90 %. V\u00FDhodou je i mo\u017Enost odb\u011Bru materi\u00E1lu k histologick\u00E9 verifikaci procesu. Snahou je p\u0159edpov\u011Bd\u011Bt \u00FAsp\u011B\u0161nost chemick\u00E9 pleurod\u00E9zy na z\u00E1klad\u011B m\u00EDry celkov\u00E9 z\u00E1n\u011Btliv\u00E9 reakce organizmu, je\u017E ud\u00E1v\u00E1 dynamika hodnot humor\u00E1ln\u00EDch a bun\u011B\u010Dn\u00FDch z\u00E1n\u011Btliv\u00FDch parametr\u016F jak v s\u00E9ru, tak v pleur\u00E1ln\u00EDm v\u00FDpotku." . "Monitoring the Effectiveness of Surgical Treatment of Malignant Pleural Effusions"@en . . "\u0160t\u011Btina, Milan" . "[2E360C2C8620]" . "23" . . "Habal, Petr" . "Man\u010F\u00E1k, Ji\u0159\u00ED" . "RIV/00179906:_____/10:10051578" . . . "CRP; biotalcum; thoracoscopy; malignant pleural effusion"@en . . . "\u0160imek, Ji\u0159\u00ED" . . "0862-495X" . . "272438" . "RIV/00179906:_____/10:10051578!RIV11-MZ0-00179906" . "Monitorace efektivity chirurgick\u00E9 l\u00E9\u010Dby malign\u00EDch pleur\u00E1ln\u00EDch v\u00FDpotk\u016F" . "Kond\u011Blkov\u00E1, Kate\u0159ina" . . . "V\u00FDchodiska: Recidivuj\u00EDc\u00ED pleur\u00E1ln\u00ED v\u00FDpotky doprov\u00E1zej\u00ED asi 10 % malign\u00EDch onemocn\u011Bn\u00ED. Opakovan\u00E9 hrudn\u00ED punkce \u010Di dren\u00E1\u017Ee mohou b\u00FDt komplikov\u00E1ny pneumotoraxem, hemotoraxem nebo infekc\u00ED pleur\u00E1ln\u00ED dutiny. Aplikace pr\u00E1\u0161kov\u00E9 formy bio talku torakoskopicky pat\u0159\u00ED k nejefektivn\u011Bj\u0161\u00EDmu paliativn\u00EDmu zp\u016Fsobu l\u00E9\u010Dby. \u00DAsp\u011B\u0161nost se pohybuje kolem 70- 90 %. V\u00FDhodou je i mo\u017Enost odb\u011Bru materi\u00E1lu k histologick\u00E9 verifikaci procesu. Snahou je p\u0159edpov\u011Bd\u011Bt \u00FAsp\u011B\u0161nost chemick\u00E9 pleurod\u00E9zy na z\u00E1klad\u011B m\u00EDry celkov\u00E9 z\u00E1n\u011Btliv\u00E9 reakce organizmu, je\u017E ud\u00E1v\u00E1 dynamika hodnot humor\u00E1ln\u00EDch a bun\u011B\u010Dn\u00FDch z\u00E1n\u011Btliv\u00FDch parametr\u016F jak v s\u00E9ru, tak v pleur\u00E1ln\u00EDm v\u00FDpotku."@cs . . "Backgrounds: Recurrent pleural effusion occured in 10% of cancer patients. Repeated thoracocentesis or drainage may be complicated by pneumothorax, haemothorax or pleural cavity infection. Thoracoscopic talc poudrage is one of the most effective pleurodesis technique in patients with malignant pleural effusions. The effectiveness of such pleurodesis is reaching the 70 to 90%. This surgical approach also allows to take a biopsy for histological verification of the process. An effort to predict the success rate of chemical pleurodesis on the basis of the body's general inflammatory reaction rate, which is determined by the dynamics of values of humoral and cellular inflammatory parameters in both serum and in pleural effusion."@en . . . . "7"^^ . "Monitorace efektivity chirurgick\u00E9 l\u00E9\u010Dby malign\u00EDch pleur\u00E1ln\u00EDch v\u00FDpotk\u016F"@cs . . . "5"^^ . "2" . "Monitorace efektivity chirurgick\u00E9 l\u00E9\u010Dby malign\u00EDch pleur\u00E1ln\u00EDch v\u00FDpotk\u016F" . . "S, Z(MZ0FNHK2005)" . . .